Medscape1d
FDA Responds to Supreme Court Decision on Advertising of Compounded Drugs
While the Supreme Court's ruling was directed at the advertising restrictions in section 503A of the Federal Food, Drug, and Cosmetic Act, it had the effect of invalidating the entire section ...
The Hill23d
Novo Nordisk asks FDA to block compounding pharmacies from making Ozempic copycats
Compounded versions of semaglutide are not approved by the FDA, and the agency earlier this month said they can pose a risk to patients. The Alliance for Pharmacy Compounding was quick to note ...
Ars Technica11d
Drugmaker shut down after black schmutz found in injectable weight-loss drug
The Food and Drug Administration is warning consumers not to use any drugs made by a compounding pharmacy in California after regulators realized the pharmacy was making drugs that need to be ...
pharmaphorum7d
FDA rethinking block on compounding of Lilly's obesity drug
The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from ... ultrasound began being applied to neurologic conditions less than a decade ago, but its ...
Woman's World on MSN14d
Is a Compounding Pharmacy Right for You? Pros, Cons & Expert Tips
With the rising demand for weight-loss medications, compounding pharmacies have been making headlines lately. On October 30, ...
CBS News23d
FDA says this weight loss drug shortage is over, but patients worry about cost and availability
Scott Brunner, CEO of the trade group Alliance for Pharmacy Compounding, says part of the problem is how the FDA determines when to resolve a shortage. "The current statute only allows them to ...
Monthly Prescribing Reference1mon
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
On October 7, a compounding trade group ... dedicated to producing more of the drug, the company announced in May. Michael Ganio, senior director of pharmacy practice and quality at the American ...
Becker's Hospital Review22d
FDA sets meeting on bulk substances: 3 notes
The FDA's Pharmacy Compounding Advisory Committee is set to meet Dec. 4 to address regulatory questions on compounding practices, according to an Oct. 25 news release from the agency. Here are ...
Fox Business1mon
Eli Lilly's tirzepatide is off the FDA's shortage list: What it means for patients
The Food and Drug Administration (FDA ... I’m not so sure," Alliance for Pharmacy Compounding CEO Scott Brunner said in a statement. Brunner suspects that "plenty of patients taking compounded ...
The Washington Post27d
Amid backlash, FDA changes course over shortage of weight-loss drugs
according to a letter it sent to the Alliance for Pharmacy Compounding on Thursday. “The abruptness of FDA’s resolution of the tirzepatide injection shortage left thousands and thousands of ...
Renal & Urology News26d
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
Shortages of tirzepatide, sold as a diabetes drug (Mounjaro) and a weight-loss medication (Zepbound), have fueled demand for compounding pharmacies to make their own versions of the medicine ...